JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NXRT
1876
NexPoint Residential Trust
NXRT
$482M
| $13.1M | ﹤0.01% |
209,105
+26,986
| +15% | +$2.05M |
2015 Q4
26 quarters
|
|
|
BBSA
1877
DELISTED
JPMorgan BetaBuilders 1-5 Year U.S. Aggregate Bond ETF
BBSA
| $13M | ﹤0.01% |
271,113
-1,128
| -0.4% | -$54.4K |
2019 Q2
12 quarters
|
|
|
GBT
1878
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $13M | ﹤0.01% |
406,113
+220,883
| +119% | +$6.47M |
2015 Q3
27 quarters
|
|
|
SWTX
1879
DELISTED
SpringWorks Therapeutics
SWTX
| $13M | ﹤0.01% |
526,829
+442,164
| +522% | +$16.2M |
2019 Q4
10 quarters
|
|
1880
Zillow
Z
$6.24B
| $13M | ﹤0.01% |
408,492
+247,288
| +153% | +$9.93M |
2015 Q4
26 quarters
|
|
1881
GFL Environmental
GFL
$17.6B
| $13M | ﹤0.01% |
502,538
+28,425
| +6% | +$843K |
2020 Q3
7 quarters
|
|
|
TXNM
1882
TXNM Energy Inc
TXNM
$6.45B
| $12.9M | ﹤0.01% |
269,712
-42,273
| -14% | -$1.98M |
2013 Q2
36 quarters
|
|
1883
PUT
Synchrony
SYF
$23.3B
| $12.8M | ﹤0.01% |
+465,100
| New | +$16.1M |
2022 Q2
0 quarters
|
|
|
X
1884
DELISTED
US Steel
X
| $12.8M | ﹤0.01% |
717,256
-308,992
| -30% | -$8.45M |
2013 Q2
36 quarters
|
|
1885
Navient
NAVI
$854M
| $12.8M | ﹤0.01% |
916,172
-157,738
| -15% | -$2.45M |
2014 Q2
32 quarters
|
|
1886
Community Bank
CBU
$3.15B
| $12.8M | ﹤0.01% |
202,491
+60,738
| +43% | +$3.98M |
2013 Q2
36 quarters
|
|
1887
Adient
ADNT
$1.35B
| $12.8M | ﹤0.01% |
431,059
-7,253
| -2% | -$244K |
2022 Q1
1 quarter
|
|
|
CONX
1888
DELISTED
CONX Corp. Class A Common Stock
CONX
| $12.8M | ﹤0.01% |
1,290,588
-149,884
| -10% | -$1.48M |
2020 Q4
6 quarters
|
|
1889
New Mountain Finance
NMFC
$664M
| $12.7M | ﹤0.01% |
1,069,198
+99,209
| +10% | +$1.28M |
2015 Q4
26 quarters
|
|
1890
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.43B
| $12.7M | ﹤0.01% |
263,312
-36,676
| -12% | -$1.78M |
2016 Q4
22 quarters
|
|
1891
CALL
Bristol-Myers Squibb
BMY
$126B
| $12.7M | ﹤0.01% |
165,100
-626,400
| -79% | -$47.7M |
2015 Q3
27 quarters
|
|
1892
Harley-Davidson
HOG
$2.58B
| $12.7M | ﹤0.01% |
399,609
+38,557
| +11% | +$1.37M |
2013 Q2
36 quarters
|
|
1893
NOV
NOV
$6.74B
| $12.6M | ﹤0.01% |
743,145
-19,854
| -3% | -$374K |
2013 Q2
36 quarters
|
|
1894
Greif
GEF
$4.64B
| $12.5M | ﹤0.01% |
200,955
-76,606
| -28% | -$4.68M |
2015 Q4
26 quarters
|
|
1895
Penske Automotive Group
PAG
$13.3B
| $12.5M | ﹤0.01% |
119,729
-542
| -0.5% | -$58.1K |
2013 Q2
36 quarters
|
|
|
DAY
1896
DELISTED
Dayforce
DAY
| $12.5M | ﹤0.01% |
266,141
-4,581,689
| -95% | -$254M |
2018 Q2
16 quarters
|
|
|
PCPC
1897
DELISTED
Periphas Capital Partnering Corporation
PCPC
| $12.5M | ﹤0.01% |
511,036
+311,436
| +156% | +$7.64M |
2022 Q1
1 quarter
|
|
1898
Delek US
DK
$4.55B
| $12.5M | ﹤0.01% |
482,337
-362,470
| -43% | -$9.78M |
2013 Q2
36 quarters
|
|
1899
Skywest
SKYW
$3.79B
| $12.5M | ﹤0.01% |
586,296
+53,574
| +10% | +$1.41M |
2015 Q3
27 quarters
|
|
1900
CALL
Coca-Cola
KO
$370B
| $12.5M | ﹤0.01% |
198,000
+65,600
| +50% | +$4.16M |
2014 Q3
31 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.